July 2006
South Dakota State Board of Pharmacy
4305 S Louise Ave, Suite 104, Sioux Falls, SD 57106
NEW REGISTERED PHARMACISTS
The following candidates recently met licensure requirements and were registered as pharmacists in South Dakota: Katie Beers, Mark Doescher, Amy Farris, Jody Garry, Amber Girard, Patrick Gunn, Sarah Haken, Karly Hegge, Brian Johnson, Warren Jurgensen, Nicole Kallenberger, Keaven Kane, Erika Kasch, Matthew Kaschmitter, Crystal Kezar, Jacob Krohn, Katie Melius, Sonya Miller, Kent Nelson, Priscilla Nelson, Jennifer Olesen, Stanley Pagel, Candy Peskey, Paul Rumpca, Amy Schroeder, Rondi Scoular, Stacey Stormo, Dustin Wagner, Thomas Wullstein.
PHARMACY LICENSES
New pharmacy licenses were recently issued to: James Stephens, Vilas Long-Term Care Pharmacy, Pierre; Amy Schroeder, Walgreens, Yankton; Kristen Bittner, Prairie Pharmacy, Corsica; Jodi Reimnitz, Walgreens, Mitchell; Kelly O’Neill, WalMart, Huron.
New licenses were issued to the following due to changes in ownership: Randy Jones, Ameripharm, Sioux Falls; Wade Johnson, Albertsons #845 dba Osco Pharmacy, Rapid City; Ken Knopik, CVS Pharmacy, Huron; Dean Klyve, Pamida, Belle Fourche; Michael Watson, Pamida, Sturgis; Ronald Nelson, Pamida, Madison; Roland Wick, Pamida, Hot Springs; John Burns, Pamida, Winner; Margaret Zard, ShopKo, Mitchell; Kevin Hed, ShopKo, Aberdeen; Roland Niewoehner, ShopKo, Watertown; Bryan Satter, ShopKo, Sioux Falls; Perry King, ShopKo, Rapid City; Rick Boettcher, ShopKo, Sioux Falls.
PHARMACISTS – Your license must be renewed by September 30. You will need to have 12 hours of continuing education credits by that date. If you have not received a renewal form by mid-September, please contact our office or visit the SDPhA website www.sdpha.org for renewal instructions. |
REGISTER TO DIPENSE ISOTRETINOIN (ACCUTANE®)
Pharmacies must register by December 30 to continue dispensing isotretinoin products. The Food and Drug Administration has approved iPLEDGE™, an enhanced risk management program designed to minimize fetal exposure to isotretinoin.
iPLEDGE requires mandatory registration of prescribers, patients, wholesalers, and pharmacies. To register go to www.ipledgeprogram.com or call 866-495-0654.
MEDICATION MIX-UPS
Your assistance is requested in helping to avoid dispensing errors. The following products– Topamax, Tegretol-XR, Tegretol and Toprol-XL – have been involved in medication mix-ups:
Your assistance is requested by the manufacturers of these drugs to help avoid future dispensing errors. Steps you can take to decrease potential errors include:
Review and provide ongoing training about accepted standards of practice related to accurate medication administration with all staff members.
Arrange product inventory to help differentiate medications from one another, especially for products with similar looking labels, names, and strengths.
Read labels several times to confirm appropriate product is being dispensed.
Be sure a pharmacist reviews all prescription orders entered into the computer and before being dispensed.
Counseling your patient is the final check and will prevent errors from leaving the pharmacy if missed during preparation.
Report medication errors to the FDA’s Med Watch program at www.fda.gov/medwatch.
CHANGE TO SCHEDULE II PRESCRIBING, EFFECTIVE JULY 1, 2006
During the 2006 South Dakota Legislative Session, new language was approved in SDCL 36-9A-12, 39-9A-13, and 36-4A-22 removing the forty-eight hour time limit for the prescription of Schedule II controlled substances by certified nurse practitioners, certified nurse midwives, and physician assistants and replacing it with 30 days. This change becomes effective July 1, 2006.
Certified nurse practitioners, certified nurse midwives, and physician assistants are to continue to work closely with collaborating or supervising physicians in all aspects of practice to ensure safe and effective patient care. The physician assistant, nurse practitioner and nurse midwives, when caring for patients may, within SDCL 36-9A-12, 39-9A-13, and 36-4A-22
COMPOUNDING OR MANUFACTURING
The question of whether a practice is compounding or manufacturing is best answered by whether you are preparing a medication pursuant to a legal prescription for a particular patient versus making a product for someone else who is selling the compounded product to the patient’s prescriber or another business.
If you are making compounded products not pursuant to an individual patient prescription and in large quantities for future sales, you will garner the attention of the FDA. Do not compound over-the-counter products – this is definitely wrong. Pharmacists may not realize they have crossed the line until regulators appear on the doorstep.
First, you should survey your compounding practices. Second, review with your State Board of Pharmacy or pharmacy regulations. Third, check with your insurance carrier such as Pharmacists Mutual, or the Pharmacy Compounding Accreditation Board (PCAB) for advice at www.pcab.info.
UPDATE ON PSEUDOEPHEDRINE
As you know, the South Dakota Legislature passed legislation that went into effect July 1, 2006. The South Dakota law prohibits the sale or purchase of more than two packages containing pseudoephedrine or ephedrine as an active ingredient unless sold or purchased with a valid prescription order prescribed by a practitioner.
Any product containing pseudoephedrine or ephedrine as an active ingredient must be displayed for sale behind a counter where the public is not permitted or in a locked case so that a customer wanting access to the package must ask a store employee for assistance; or the products may be displayed without restriction if the product contains any type of anti-theft device system including an electronic anti-theft device system that utilizes a product tag and detection alarm which prevents the theft of the product.
Retail businesses offering products for sale containing pseudoephedrine or ephedrine shall require identification of the person purchasing the products. Identification must contain a photo such as a driver’s license. The retailer must maintain a record including the purchaser’s name and date of birth. On August 1, 2006, and no later than the fifth day of every month thereafter, the retailer shall send such records to the Office of the Attorney General, Pierre, South Dakota. A designated form is available from the Board of Pharmacy office to record the information.
No person may possess, receive, or otherwise acquire more than nine grams of ephedrine base or pseudoephedrine base in any product, mixture, or preparation within any thirty day period. Any violation of the above legislation is a Class 1 misdemeanor. The entire state law is printed in the April 2006 issue of the Board of Pharmacy Newsletter.
